Sandra Groscurth
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.
Publications of Sandra Groscurth
Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1
Nature. 01/2011; 469:419-423.
Human epithelia are permanently challenged by bacteria and fungi, including commensal and pathogenic microbiota. In the gut, the fraction of strict anaerobes increases from proximal to distal,
Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1
Keystone Symposium, Mucosal Biology: A Fine Balance between Tolerance and Immunity, Vancouver, British Columbia; 01/2011
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.
Nature. 01/2011; 469(7330):419-23.
Human epithelia are permanently challenged by bacteria and fungi, including commensal and pathogenic microbiota. In the gut, the fraction of strict anaerobes increases from proximal to distal,
An unfolded CH1 domain controls the assembly and secretion of IgG antibodies.
Molecular cell. 07/2009; 34(5):569-79.
A prerequisite for antibody secretion and function is their assembly into a defined quaternary structure, composed of two heavy and two light chains for IgG. Unassembled heavy chains are actively
The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity.
Proceedings of the National Academy of Sciences of the United States of America. 10/2008; 105(36):13373-8.
Folding intermediates play a key role in defining protein folding and assembly pathways as well as those of misfolding and aggregation. Yet, due to their transient nature, they are poorly accessible
Are you Sandra Groscurth?
Claim your profileCo-Authors of Sandra Groscurth
Top Primary Authors
Top Secondary Authors
- Zhihong Wu (2)
- Zhihong Wu (1)
Top Senior Authors
- Jan Wehkamp (3)
- Johannes Buchner (2)
Top Journals
Keywords of Sandra Groscurth
antibody domains
defined quaternary structure
Human β-defensin 1
innate immune defence
key effector molecules
low redox potential
molecular chaperone BiP
reduced hBD-1 shields
strict anaerobes increases
Unassembled heavy chains
